The iscom structure as an immune-enhancing moiety: experience with viral systems-Reference-Cited by-同舟云学术

The iscom structure as an immune-enhancing moiety: experience with viral systems

Published:1992-01 Issue:5 Volume:143 Page:531-541
ISSN:0923-2494
Container-title:Research in Immunology
language:en
Short-container-title:Research in Immunology

Author:

Claassen I.,Osterhaus A.

Publisher

Elsevier BV

Subject

Immunology

Reference55 articles.

1. Formation and characterization of FeLV iscoms;Åkerblom;Vaccine,1989

2. Protective effect of an iscom bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes;Carlson;Vaccine,1991

3. A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity with special reference to the application in the vaccination of cattle against foot-and-mouth disease;Dalsgaard;Acta. Vet. Scand.,1978

4. Measles virus fusion protein presented in an immunestimulating complex (iscom) induces haemolysisinhibiting and fusion-inhibiting antibodies, virusspecific T cells and protection in mice;De Vries;J. gen. Virol.,1988

5. Canine distemper virus (CDV) immune-stimulating complexes (iscoms), but not measles virus iscoms, protect dogs against CDV infection;De Vries;J. gen. Virol.,1988

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine Nanocarriers;Biomedical Engineering;2018

2. An Indian Perspective of Some Recent Developments in Polio, DPT, Zika and Rotavirus Vaccines;Indian Journal of Pharmaceutical Sciences;2017

3. Saponin Interactions with Model Membrane Systems – Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs;Planta Medica;2016-10-19

4. Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs;Drug Safety;2015-10-08

5. Vaccine Nanocarriers;Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering;2015